What the company does
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
What the weekly tape is saying
VETO closed the latest completed week at 69.90 EUR. The 4-week return is -0.2% and the 12-week return is -11.1%. Trend Signal is inactive, Market Dynamics is -0.93. Setup signature: Risk-first tape with a 36/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 79.00 EUR
- Vs Trend Line
- -11.5%
- Fair Value
- 83.41 EUR
- Vs Fair Value
- -16.2%
- 52W High
- 91.50 EUR
- 52W Low
- 67.20 EUR
- Drawdown
- -23.6%
- Range Position
- 11.1%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 30
- 52W Active Breadth
- 57.7%
- Sector Scope
- FR Healthcare
- Sector Rank
- 17 of 76
- Sector Percentile
- 78.7%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
FR Healthcare
- Tracked Peers
- 76
- 4W Rank
- 27 of 76
- Avg 1W
- -2.1%
- Avg 4W
- -5.9%
- Trend Breadth
- 28.9%
- Positive MD
- 48.7%
FR Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 5
- 4W Rank
- 2 of 5
- Avg 1W
- -0.9%
- Avg 4W
- -5.0%
- Trend Breadth
- 20.0%
- Positive RS
- 40.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.93
- 4W MD Change
- -27.3%
- Relative Strength
- -13.56
- 4W RS Change
- -41.3%
- Expectation
- Undecided
- Probability
- 45.63%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 29.5K
- 13W Average
- 17.7K
- 52W Average
- 17.4K
- Vs 13W
- 1.7x
- Vs 52W
- 1.7x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 2.5%
- 52W Volatility
- 3.0%
- Upside Weeks
- 26
- Downside Weeks
- 25
- Downside Breadth
- 48.1%
- Avg Gain / Loss
- 2.3% / -2.4%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- PAR
- Country
- FR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- EUR
- Market Cap
- 828.8M
Opportunity signals
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 69.90 EUR | 0.6% | 79.00 EUR | 83.41 EUR | -0.93 | -13.56 | 29.5K | Off |
| 5 Jun 2026 | 69.50 EUR | -2.3% | 79.08 EUR | 83.53 EUR | -0.92 | -12.82 | 53.0K | Off |
| 29 May 2026 | 71.13 EUR | -0.3% | 79.16 EUR | 83.65 EUR | -0.85 | -10.55 | 20.7K | Off |
| 22 May 2026 | 71.33 EUR | 1.8% | 79.27 EUR | 83.75 EUR | -0.81 | -9.71 | 20.3K | Off |
| 15 May 2026 | 70.04 EUR | -4.4% | 79.50 EUR | 83.85 EUR | -0.73 | -9.60 | 15.9K | Off |
| 8 May 2026 | 73.30 EUR | -3.5% | 79.80 EUR | 83.98 EUR | -0.77 | -7.34 | 16.3K | Off |
| 1 May 2026 | 75.96 EUR | -6.0% | 79.95 EUR | 84.09 EUR | -0.80 | -4.05 | 10.8K | Off |
| 24 Apr 2026 | 80.80 EUR | 2.4% | 80.04 EUR | 84.19 EUR | -0.89 | 1.49 | 11.8K | Off |
| 17 Apr 2026 | 78.92 EUR | -0.2% | 79.92 EUR | 84.22 EUR | -0.91 | -3.95 | 8.4K | Off |
| 10 Apr 2026 | 79.12 EUR | 2.3% | 79.91 EUR | 84.26 EUR | -0.89 | -1.98 | 11.7K | Off |
| 3 Apr 2026 | 77.34 EUR | -0.8% | 79.97 EUR | 84.29 EUR | -0.90 | -0.78 | 5.9K | Off |
| 27 Mar 2026 | 78.00 EUR | -0.8% | 79.90 EUR | 84.32 EUR | -0.73 | 3.32 | 17.1K | Off |
| 20 Mar 2026 | 78.60 EUR | 0.4% | 79.83 EUR | 84.38 EUR | -0.49 | 4.60 | 9.0K | On |
| 13 Mar 2026 | 78.30 EUR | -0.3% | 79.72 EUR | 84.40 EUR | -0.08 | 0.91 | 8.7K | On |